[Effect of circBIRC6 targeting miR-367-3p on cisplatin resistance of ovarian cancer cells].

Zhang, J; Bai, H J

Zhang, J; Bai, H J.

Affiliation

Zhang J; Department of Gynecological Oncology, Zhengzhou University Affiliated Cancer Hospital, Henan Cancer Hospital, Zhengzhou 450008, China.
Bai HJ; Department of Gynecological Oncology, Zhengzhou University Affiliated Cancer Hospital, Henan Cancer Hospital, Zhengzhou 450008, China.

Zhonghua Zhong Liu Za Zhi ; 43(10): 1062-1068, 2021 Oct 23.

Article in Zh | MEDLINE | ID: mdl-34695896

Subject(s)

Antineoplastic Agents; Drug Resistance, Neoplasm; MicroRNAs; Ovarian Neoplasms; RNA, Circular/genetics; Antineoplastic Agents/pharmacology; Antineoplastic Agents/therapeutic use; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin/pharmacology; Cisplatin/therapeutic use; Drug Resistance, Neoplasm/genetics; Female; Humans; Inhibitor of Apoptosis Proteins; MicroRNAs/genetics; Ovarian Neoplasms/drug therapy; Ovarian Neoplasms/genetics

Key words

Apoptosis; CircBIRC6; Cisplatin; Drug resistance; Micro-367-3p; Ovarian neoplasms; Proliferation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Drug Resistance, Neoplasm / MicroRNAs / RNA, Circular / Antineoplastic Agents Limits: Female / Humans Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2021 Document type: Article Affiliation country: China Country of publication: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google